Clinical Trial Update: Osteoporosis in RETT Syndrome [NA]

View source ↗

Summary

A completed clinical trial conducted in Paris studied osteoporosis in patients with Rett syndrome caused by MECP2 mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Rett Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: RETT Syndrome With Proven MECP2 Mutation | NA | Status: COMPLETED